Canaccord Genuity Maintains a 'Hold' on Oracle (ORCL); Possible Short-Term Play, But...
Tweet Send to a FriendGet Alerts ORCL Hot Sheet
Price: $34.90 -0.37%
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Trade ORCL Now!
Canaccord Genuity maintains a 'Hold' on Oracle (NASDAQ: ORCL) price target of $30.00.
Analyst, Richard Davis, said, "We believe ORCL shares are due for a short-term bounce when the company reports its May quarter (Q4/12) on June 21. However, we do not believe the firm’s fundamentals are sufficiently strong to produce a sustained rally. In our opinion, this means that our continued HOLD rating is warranted."
For an analyst ratings summary and ratings history on Oracle click here. For more ratings news on Oracle click here.
Shares of Oracle closed at $27.53 yesterday, with a 52 week range of $24.72-$34.13.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Richard Davis, said, "We believe ORCL shares are due for a short-term bounce when the company reports its May quarter (Q4/12) on June 21. However, we do not believe the firm’s fundamentals are sufficiently strong to produce a sustained rally. In our opinion, this means that our continued HOLD rating is warranted."
For an analyst ratings summary and ratings history on Oracle click here. For more ratings news on Oracle click here.
Shares of Oracle closed at $27.53 yesterday, with a 52 week range of $24.72-$34.13.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Needham & Company Lifts Numbers on 3D Systems (DDD) on Offering, RDPG Deal
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
Create E-mail Alert Related Categories
Analyst CommentsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

